批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/11/21 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/12/22 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/08/26 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/08/02 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/04/28 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/09/24 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/07/28 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/05/09 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/04/01 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/03 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/03/07 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/08 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2010/12/21 |
SUPPL-16(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/09/11 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2009/02/25 |
SUPPL-14(补充) |
Approval |
Labeling |
901 REQUIRED
|
|
|
2007/08/24 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/01/25 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/07/08 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/05/20 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/10/03 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/02/22 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/07/20 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/15 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/03/16 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/12/24 |
ORIG-1(原始申请) |
Approval |
Type 4 - New Combination |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:DICLOFENAC SODIUM; MISOPROSTOL 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL 规格:50MG;0.2MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020607 |
001 |
NDA |
ARTHROTEC |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Prescription |
Yes |
No |
AB |
1997/12/24
|
PFIZER |
201089 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Prescription |
No |
No |
AB |
2012/07/09
|
ACTAVIS LABS FL INC |
200158 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Discontinued |
No |
No |
AB |
2013/05/09
|
SANDOZ |
203995 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Prescription |
No |
No |
AB |
2016/11/25
|
AMNEAL PHARMS |
205143 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Prescription |
No |
No |
AB |
2020/02/19
|
YUNG SHIN PHARM |
204355 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Prescription |
No |
No |
AB |
2021/07/15
|
MICRO LABS |
206771 |
001 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
50MG;0.2MG |
Discontinued |
No |
No |
AB |
2023/06/12
|
ZYDUS PHARMS |
活性成分:DICLOFENAC SODIUM; MISOPROSTOL 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL 规格:75MG;0.2MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020607 |
002 |
NDA |
ARTHROTEC |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Prescription |
Yes |
Yes |
AB |
1997/12/24
|
PFIZER |
201089 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Prescription |
No |
No |
AB |
2012/07/09
|
ACTAVIS LABS FL INC |
200158 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Discontinued |
No |
No |
AB |
2013/05/09
|
SANDOZ |
203995 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Prescription |
No |
No |
AB |
2016/11/25
|
AMNEAL PHARMS |
205143 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Prescription |
No |
No |
AB |
2020/02/19
|
YUNG SHIN PHARM |
204355 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Prescription |
No |
No |
AB |
2021/07/15
|
MICRO LABS |
206771 |
002 |
ANDA |
DICLOFENAC SODIUM AND MISOPROSTOL |
DICLOFENAC SODIUM; MISOPROSTOL |
TABLET, DELAYED RELEASE;ORAL |
75MG;0.2MG |
Discontinued |
No |
No |
AB |
2023/06/12
|
ZYDUS PHARMS |